Custom assay development for advanced drug discovery
Inaphaea Biolabs is a translational contract research organisation, offering cell-based assays specialising in oncology and women’s health.
Registered Supplier on Scientist.com the world’s largest online research marketplace.
Who we are
Inaphaea provides pharma partners with customised immuno and cancer cell-based assays for early drug discovery research and pre-clinical development. Speak to our expert team about our assay development services today.
OUR PROCESS
An important element of our overall service delivery is our direct-to-scientist communication access.
As an extension of your research team, we aim to make interaction easy from the outset of the project through to completion.
For custom drug discovery projects, we will work closely with you to meet your exact specifications.
Once the experiment is complete, our scientists can discuss the data as required and provide recommendations of next steps.
OUR SERVICES
Latest News
- Inaphaea Biolabs to collaborate on Advanced Evaluation of Second-Generation RNA Helicase InhibitorInaphaea Biolabs Ltd, the wholly owned subsidiary of ValiRx plc, focused on advanced in-vitro and translational biology services, has announced…
- Inside the evolving world of drug discovery: a conversation with Dr Cathy Tralau-StewartDr Cathy Tralau-Stewart is an experienced therapeutics development scientist and pharmacologist. Working within some of the world’s leading pharma and…
- Inaphaea expands PDC Platform with digital avatars and collaborative cancer researchInaphaea continues to drive innovation in drug development through its cutting-edge work with Patient-Derived Cells (PDCs), advanced in-silico modelling, and…
Your PDCs questions, answered.
Contact our lab team now to use our expertise to design your experimental plan
